Dennis Franklin v. HHS - Pneumococcal, Guillain-Barré syndrome (GBS) (2023)
Case summary [AI summaries can sometimes make mistakes]
Dennis Franklin filed a petition on February 8, 2021, seeking compensation under the National Vaccine Injury Compensation Program. He alleged that he suffered from Guillain-Barré syndrome (GBS) as a result of receiving the pneumococcal conjugate and/or tetanus, diphtheria, acellular pertussis vaccines on January 28, 2019.
Mr. Franklin also alleged that he experienced residual effects of this injury lasting more than six months.
The respondent denied that the vaccines caused his GBS or any other injury, and denied that his current condition was a sequelae of a vaccine-related injury. Despite these positions, both parties agreed to settle the case.
The court reviewed the file and adopted the parties' stipulation as its decision. Chief Special Master Brian H.
Corcoran awarded Dennis Franklin $45,000.00 as compensation for all damages. The decision was issued on July 7, 2023.
Joseph Alexander Vuckovich represented the petitioner, and Alexa Roggenkamp represented the respondent.
Theory of causation
Petitioner Dennis Franklin alleged that he suffered Guillain-Barré syndrome (GBS) as a result of receiving the pneumococcal conjugate and/or tetanus, diphtheria, acellular pertussis vaccines on January 28, 2019, with residual effects lasting more than six months. The respondent denied causation. The parties reached a stipulation to settle the case. Chief Special Master Brian H. Corcoran adopted the stipulation, awarding $45,000.00 to Petitioner. The public decision does not describe the specific medical theory of causation, expert testimony, or the mechanism of injury. Petitioner counsel was Joseph Alexander Vuckovich, and respondent counsel was Alexa Roggenkamp. The decision date was July 7, 2023.
Source PDFs
USCOURTS-cofc-1_21-vv-00885